127 related articles for article (PubMed ID: 12794473)
21. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
[TBL] [Abstract][Full Text] [Related]
22. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of antithrombin in the prevention of microvascular thrombosis during endotoxemia: an intravital microscopic study.
Sorg H; Hoffmann JN; Rumbaut RE; Menger MD; Lindenblatt N; Vollmar B
Thromb Res; 2007; 121(2):241-8. PubMed ID: 17512574
[TBL] [Abstract][Full Text] [Related]
24. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
[TBL] [Abstract][Full Text] [Related]
25. Effects of lipo-prostaglandin E1 on wound bed microcirculation.
Hasegawa H; Ichioka S
J Wound Care; 2015 Jul; 24(7):293-4, 296, 298-9. PubMed ID: 26198551
[TBL] [Abstract][Full Text] [Related]
26. Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid.
Tomikawa M
Thromb Diath Haemorrh; 1975 Sep; 34(1):145-58. PubMed ID: 1188708
[TBL] [Abstract][Full Text] [Related]
27. Continuous local intraarterial infusion of antithrombotic agents for epigastric flap transfer in rabbit.
Maeda M; Fukui A; Inada Y; Tamai S; Mizumoto S
J Reconstr Microsurg; 1990 Jul; 6(3):261-6. PubMed ID: 2292789
[TBL] [Abstract][Full Text] [Related]
28. Comparative study on the antithrombotic effects of a synthetic thrombin inhibitor and of heparin in animal models.
Hauptmann J; Barth A; Schönberger FP; Markwardt F
Biomed Biochim Acta; 1983; 42(7-8):959-65. PubMed ID: 6651812
[TBL] [Abstract][Full Text] [Related]
29. New model for in vivo quantification of microvascular embolization, thrombus formation, and recanalization in composite flaps.
Rücker M; Schäfer T; Stamm A; Saueressig K; Vollmar B; Spitzer WJ; Menger MD
J Surg Res; 2002 Nov; 108(1):129-37. PubMed ID: 12443725
[TBL] [Abstract][Full Text] [Related]
30. Thromboembolic reaction following wall puncture in arterioles and venules of the rabbit mesentery.
oude Egbrink MG; Tangelder GJ; Slaaf DW; Reneman RS
Thromb Haemost; 1988 Feb; 59(1):23-8. PubMed ID: 3363530
[TBL] [Abstract][Full Text] [Related]
31. The effect of photodynamic therapy on the microcirculation.
Reed MW; Miller FN; Wieman TJ; Tseng MT; Pietsch CG
J Surg Res; 1988 Nov; 45(5):452-9. PubMed ID: 2972887
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation.
Reed MW; Wieman TJ; Schuschke DA; Tseng MT; Miller FN
Radiat Res; 1989 Sep; 119(3):542-52. PubMed ID: 2772144
[TBL] [Abstract][Full Text] [Related]
33. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
Kaiser B; Hauptmann J; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
[TBL] [Abstract][Full Text] [Related]
34. A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.
Buchanan MR; Brister SJ
Wien Klin Wochenschr; 1999 Feb; 111(3):81-9. PubMed ID: 10093889
[TBL] [Abstract][Full Text] [Related]
35. [Antithrombotic effects of molsidomine alone and in combination with other antithrombotic agents in a thrombosis model of the microcirculation of the rat].
Giedrojc J; Weichert W; Breddin HK
Z Kardiol; 1991; 80 Suppl 5():35-9. PubMed ID: 1663678
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic and platelet activating effects of heparin in prevention of microarterial thrombosis.
Arnljots B; Dougan P; Bergqvist D
Plast Reconstr Surg; 1997 Apr; 99(4):1122-8. PubMed ID: 9091912
[TBL] [Abstract][Full Text] [Related]
37. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
Cadroy Y; Harker LA; Hanson SR
J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985
[TBL] [Abstract][Full Text] [Related]
39. Effects of inspired oxygen concentration on peripheral microcirculation studied by the rabbit ear chamber method.
Komori M; Takada K; Ozaki M
In Vivo; 2001; 15(4):303-8. PubMed ID: 11695222
[TBL] [Abstract][Full Text] [Related]
40. Heparin prevents stasis-induced thrombosis through protection of the venous endothelial cells: an electron microscopic study in rabbits.
Trabucchi E; Foschi D; Marazzi M; Abelli P; Andriuoli G; Lami F; Scagnol I; Del Soldato P; De Santis F; Montorsi W
Haemostasis; 1991; 21(1):37-44. PubMed ID: 1864555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
